CancerNav™ Technology
Improving the therapeutic response to cancer drugs
CancerNav™ is an advanced technology platform that will make cancer drug treatments more effective. It uses a predictive biomarker to identify exactly which drug a tumour is most likely to respond too. This approach can dramatically improve the success of the treatment and improve the quality of care provided to the patient.
CancerNav™ underpins all the drug developments at Celleron
Patients recruited into clinical trials are stratified into likely responder groups based on expression of a predictive biomarker identified by CancerNav™. This allows a robust hypothesis-driven route to early clinical proof-of-concept thereby reducing the significant economic burden of drug development.
Shortening drug development time and increasing the probability of clinical success
Using the CancerNav™ platform to underpin the pre-clinical testing regime and the clinical trial design of our proprietary products significantly shortens the drug development time lines whilst increasing the probability of clinical success.
Significantly reducing the cost of developing drugs
The CancerNav™ approach allows a robust route to early clinical proof-of-concept and thereby reduces the significant economic burden of drug development. The application of CancerNav™ to Celleron’s clinical development early patient selection and stratification strategy is shown below:
CancerNav™ Services
Celleron provides the CancerNav™ screen on a contract basis. CancerNav can be applied to assist the development of drugs from other Oncology Companies. Interested parties should >> Contact us now.
CancerNav™ underpins all the drug developments at Celleron
Patients recruited into clinical trials are stratified into likely responder groups based on expression of a predictive biomarker identified by CancerNav™. This allows a robust hypothesis-driven route to early clinical proof-of-concept thereby reducing the significant economic burden of drug development.
Shortening drug development time and increasing the probability of clinical success
Using the CancerNav™ platform to underpin the pre-clinical testing regime and the clinical trial design of our proprietary products significantly shortens the drug development time lines whilst increasing the probability of clinical success.
Significantly reducing the cost of developing drugs
The CancerNav™ approach allows a robust route to early clinical proof-of-concept and thereby reduces the significant economic burden of drug development. The application of CancerNav™ to Celleron’s clinical development early patient selection and stratification strategy is shown below:
CancerNav™ Services
Celleron provides the CancerNav™ screen on a contract basis. CancerNav can be applied to assist the development of drugs from other Oncology Companies. Interested parties should >> Contact us now.
Shortening drug development time and increasing the probability of clinical success
Using the CancerNav™ platform to underpin the pre-clinical testing regime and the clinical trial design of our proprietary products significantly shortens the drug development time lines whilst increasing the probability of clinical success.
Significantly reducing the cost of developing drugs
The CancerNav™ approach allows a robust route to early clinical proof-of-concept and thereby reduces the significant economic burden of drug development. The application of CancerNav™ to Celleron’s clinical development early patient selection and stratification strategy is shown below:
CancerNav™ Services
Celleron provides the CancerNav™ screen on a contract basis. CancerNav can be applied to assist the development of drugs from other Oncology Companies. Interested parties should >> Contact us now.
Significantly reducing the cost of developing drugs
The CancerNav™ approach allows a robust route to early clinical proof-of-concept and thereby reduces the significant economic burden of drug development. The application of CancerNav™ to Celleron’s clinical development early patient selection and stratification strategy is shown below:
CancerNav™ Services
Celleron provides the CancerNav™ screen on a contract basis. CancerNav can be applied to assist the development of drugs from other Oncology Companies. Interested parties should >> Contact us now.